Only BAP1 protein expression data by reverse-phase protein arrays (RPPAs) are available in the TCPA dataset, where BAP1 serves as a strong prognostic predictor for female-related cancer cohorts including samples of invasive breast carcinoma, Ovarian serous cystadenocarcinoma, Uterine Corpus Endometrial Carcinoma (25). This evidence concerns the gene BAP1 and ovarian serous cystadenocarcinoma.